Comparison of the helical tomotherapy against the multileaf collimator-based intensity-modulated radiotherapy and 3D conformal radiation modalities in lung cancer radiotherapy

British Journal of Radiology

Volumn 84, Issue 998, 2011, Pages 161-172

  Mavroidis, P ^a,b   Shi, C ^c   Plataniotis, G A ^d   Delichas, M G ^e   Costa Ferreira, B ^f   Rodriguez, S ^c   Lind, B K ^a   Papanikolaou, N ^c  

^a STOCKHOLM UNIVERSITY   (Sweden)

^b UNIVERSITY HOSPITAL OF LARISSA   (Greece)

^c UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO   (United States)

^d ABERDEEN ROYAL INFIRMARY   (United Kingdom)

^e ARISTOTLE UNIVERSITY OF THESSALONIKI   (Greece)

^f UNIVERSITY OF AVEIRO   (Portugal)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; CANCER PATIENT; CANCER RADIOTHERAPY; CASE REPORT; CLINICAL ASSESSMENT; COLLIMATOR; COMPARATIVE STUDY; COMPUTER ASSISTED RADIOTHERAPY; CONTROLLED STUDY; DISEASE ASSOCIATION; FEMALE; HUMAN; INTENSITY MODULATED RADIATION THERAPY; INTERMETHOD COMPARISON; LINEAR ACCELERATOR; LUNG CANCER; MALE; MIXED LYMPHOCYTE CULTURE; OPTIMAL DRUG DOSE; THREE DIMENSIONAL IMAGING; TOMOTHERAPY;

DOSE-RESPONSE RELATIONSHIP, RADIATION; FEMALE; HUMANS; LUNG NEOPLASMS; MALE; RADIOTHERAPY DOSAGE; RADIOTHERAPY PLANNING, COMPUTER-ASSISTED; RADIOTHERAPY, CONFORMAL; RADIOTHERAPY, INTENSITY-MODULATED; TOMOGRAPHY, SPIRAL COMPUTED;

EID: 78751692666     PISSN: 00071285     EISSN: None     Source Type: Journal    
DOI: 10.1259/bjr/89275085     Document Type: Article

References (43)

1. Aaltonen P, Brahme A, Lax I, Levernes S, Näslund I, Reitan JB, et al. Specification of dose delivery in radiation therapy. Recommendations by the Nordic Association of Clinical Physics (NACP). Acta Oncol 1997;36(Suppl 10):1-32.
2. ICRU report 62. Prescribing, recording and reporting photon beam therapy (supplement to ICRU report 50). International Commission on Radiation Units and Measurements 1999: 1-52.
3. Mavroidis P, Lind BK, Van Dijk J, Koedooder K, De Neve W, De Wagter C, et al. Comparison of conformal radiation therapy techniques within the dynamic radiotherapy project 'Dynarad'. Phys Med Biol 2000;45:2459-81.
4. Mackie TR, Balog J, Ruchala KJ, Shepard D, Aldridge JS, Fitchard EE, et al. TomoTherapy. Sem Radiat Oncol 1999;9:108-17.
5. Webb S. Intensity-modulated radiation therapy. Bristol: IOP Publishing, 2000.
6. Scrimger RA, Tome WA, Olivera GH, Reckwerdt PJ, Mehta MP, Fowler JF. Reduction in radiation dose to lung and other normal tissues using helical tomotherapy to treat lung cancer, in comparison to conventional field arrangements. Am J Clin Oncol 2003;26:70-8.
7. Bauman G, Yartsev S, Coad T, Fisher B, Kron T. Helical TomoTherapy for craniospinal radiation. Br J Radiol 2005;78:548-52.
8. Mavroidis P, Lind BK, Brahme A. Biologically effective uniform dose (Dcombining double overline) for specification, report and comparison of dose response relations and treatment plans. Phys Med Biol 2001;46:2607-30.
9. Källman P, Lind BK, Brahme A. An algorithm for maximizing the probability of complication free tumour control in radiation therapy. Phys Med Biol 1992;37:871-90.
10. Brahme A. Which parameters of the dose distribution are best related to the radiation response of tumours and normal tissues? Proceedings of the Interregional Seminars for Europe, the Middle East and Africa. Organized by the IAEA, Leuven, 1994: 37-58.
11. Emami B, Lyman J, Brown A, Coia L, Goitein M, Munzenrider JE, et al. Tolerance of normal tissue to therapeutic irradiation. Int J Radiat Oncol Biol Phys 1991;21:109-22.
12. Ågren AK. Quantification of the response of heterogeneous tumors and organized normal tissues to fractionated radiotherapy. PhD Thesis. Stockholm University, 1995.
13. Mavroidis P, Laurell G, Kraepelien T, Fernberg JO, Lind BK, Brahme A. Determination and clinical verification of dose-response parameters for esophageal stricture from head and neck radiotherapy. Acta Oncol 2003;42:865-81.
14. Mavroidis P, al-Abany M, Helgason AR, Ågren Cronqvist AK, Wersäll P, Theodorou K, et al. Dose-response relations for anal sphincter regarding faecal leakage and blood or phlegm in stools after radiotherapy for prostate cancer. Strahlenther Onkol 2005;181:293-306.
15. Papanikolaou N, Mackie TR, Meger-Wells C, Gehring M, Reckwerdt P. Investigation of the convolution method for polyenergetic spectra. Med Phys 1993;20:1327-36.
16. Mackie TR, Scrimger JW, Battista JJ. A convolution method of calculating dose for 15-MV x-rays. Med Phys 1985;12:188-96.
17. Papanikolaou N, Shi C. A useful tool for trial comparison and developing composite plan between tomotherapy and Pinnacle. Med Phys 2006;33:2065.
18. Ågren-Cronqvist AK, Brahme A, Turesson I. Optimization of uncomplicated control for head and neck tumors. Int J Radiat Oncol Biol Phys 1990;19:1077-85. (Pubitemid 20345184)
19. Källman P, Ågren AK, Brahme A. Tumor and normal tissue responses to fractionated non uniform dose delivery. Int J Radiat Biol 1992;62:249-62.
20. Jackson A, Ten Haken RK, Robertson JM, Kessler ML, Kutcher GJ, Lawrence TS. Analysis of clinical complication data for radiation hepatitis using a parallel architecture model. Int J Radiat Oncol Biol Phys 1995;31:883-91.
21. Gagliardi G, Bjöhle J, Lax I, Ottolenghi A, Eriksson F, Liedberg A, et al. Radiation pneumonitis after breast cancer irradiation: Analysis of the complication probability using the relative seriality model. Int J Radiat Oncol Biol Phys 2000;46:373-81.
22. Lind BK, Mavroidis P, Hyödynmaa S, Kappas C. Optimization of the dose level for a given treatment plan to maximize the complication free tumor cure. Acta Oncol 1999;38:787-98. (Pubitemid 29441442)
23. Burman C, Kutcher GJ, Emami B, Goitein M. Fitting of normal tissue tolerance data to an analytical function. Int J Radiat Oncol Biol Phys 1991;21:123-35.
24. Kutcher GJ, Burman C, Brewster L, Goitein M, Mohan R. Histogram reduction method for calculating complication probabilities for 3-dimensional treatment planning evaluations. Int J Radiat Oncol Biol Phys 1991;21:137-46.
25. Kwa S, Theuws C, Wagendar A, Damen EM, Boersma LJ, Baas P, et al. Evaluation of two dose-volume histogram reduction models for the prediction of radiation pneumonitis. Radiother Oncol 1998;48:61-9. (Pubitemid 28391969)
26. Boersma LJ, Damen EM, De Boer RW. Estimation of overall pulmonary function after irradiation using dose-effect relations for local functional injury. Radiother Oncol 1995;36:15-23.
27. Eriksson F, Gagliardi G, Liendberg A, Lax I, Lee C, Levitt S, et al. Long-term cardiac mortality following radiation therapy for Hodgkin's disease: analysis with the relative seriality model. Radiother Oncol 2000;55:153-62.
28. Roesink JM, Moerland MA, Battermann JJ, Hordijk GJ, Terhaard CHJ. Quantitative dose-volume response analysis of changes in parotid gland function after radiotherapy in the head-and-neck region. Int J Radiat Oncol Biol Phys 2001;51:938-46.
29. Willner J, Baier K, Caragiani E, Tschammler A, Flentje M. Dose, volume, and tumor control predictions in primary radiotherapy of non-small-cell lung cancer. Int J Radiat Oncol Biol Phys 2002;52:382-9.
30. Tsougos I, Nilsson P, Theodorou K, Kjellén E, Ewers SB, Jarlman O, et al. NTCP modeling and pulmonary function tests evaluation for the prediction of radiation induced pneumonitis in non-small-cell lung cancer radiotherapy. Phys Med Biol 2007;52:1055-73.
31. Deasy JO. Inter-patient and intra-tumor radiosensitivity heterogeneity Volume and kinetics in tumor control and normal tissue complications. Madison, WI: Medical Physics Publishing, 1997: 363-81.
32. Brahme A. The need for accurate target and dose specifications in conventional and conformal radiation therapy - an introduction. Acta Oncol 1997;36:789-92.
33. Kölbl O, Richter S, Flentje M. Influence of treatment technique on dose-volume histogram and normal tissue complication probability for small bowel and bladder. Strahlenther Onkol 2000;176:105-11.
34. Kron T, Grigorov G, Yu E, Yartsev S, Chen JZ, Wong E, et al. Planning evaluation of radiotherapy for complex lung cancer cases using helical tomotherapy. Phys Med Biol 2004;49:3675-90.
35. Brahme A. Development of radiation therapy optimization. Acta Oncol 2000;39:579-95.
36. Pezner RD, Liu A, Han C, Chen YJ, Schultheiss TE, Wong JYC. Dosimetric comparison of helical tomotherapy treatment and step-and-shoot intensity-modulated radiotherapy of retroperitoneal sarcoma. Radiother Oncol 2006;81:81-7. (Pubitemid 44540228)
37. Papanikolaou N, Yan Y, Penagaricano J, Ratanatharathorn V. The impact of daily patient setup error and tissue inhomogeneity on PTV coverage and OAR avoidance using IMRT. Med Phys 2002;29:1286.
38. Lind BK. Radiation therapy planning and optimization studied as inverse problems. PhD Thesis. Stockholm University, 1991.
39. Löf J, Lind BK, Brahme A. Optimal radiation beam profiles considering the stochastic process of patient positioning in fractionated radiation therapy. Inverse Problems 1995;11:1189-209.
40. Buffa FM, Davidson SE, Hunter RD, Nahum AE, West CM. Incorporating biologic measurements (SF2, CFE) into a tumor control probability model increases their prognostic significance: a study in cervical carcinoma treated with radiation therapy. Int J Radiat Oncol Biol Phys 2001;50:1113-22.
41. Fenwick JD, Nahum AE. Series model volume effects in a population of non-identical patients: how low is low? Phys Med Biol 2001;46:1815-34.
42. Nahum AE, Movsas B, Horwitz EM, Stobbe CC, Chapman JD. Incorporating clinical measurements of hypoxia into tumor local control modeling of prostate cancer: implications for the alpha/beta ratio. Int J Radiat Oncol Biol Phys 2003;57:391-401. (Pubitemid 37040935)
43. Ferreira BC, Svensson R, Löf J, Brahme A. The clinical value of non-coplanar photon beams in biologically optimized intensity modulated dose delivery on deep seated tumors. Acta Oncol 2003;42:852-64. (Pubitemid 38091186)